Showing results (41-50 of 58) with videos related to
Sort By:
Pageof 6
Haematologica|March 4, 2014
ATM mutation rather than BIRC3 deletion and/or mutation predicts reduced survival in 11q-deleted chronic lymphocytic leukemia: data from the UK LRF CLL4 trialMatthew J J Rose-Zerilli, Jade Forster, Helen Parker, et al.Cancer Research|April 12, 2013
PFI-1, a highly selective protein interaction inhibitor, targeting BET BromodomainsSarah Picaud, David Da Costa, Angeliki Thanasopoulou, et al.The American Journal of Pathology|July 24, 2003
Variations in ATM protein expression during normal lymphoid differentiation and among B-cell-derived neoplasiasJane Starczynski, William Simmons, Joanne R Flavell, et al.Leukemia & Lymphoma|April 26, 2013
Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemiaG Doreen te Raa, Jitka Malcikova, Sarka Pospisilova, et al.The Journal of Pathology|January 15, 2009
The ATM tumour suppressor gene is down-regulated in EBV-associated nasopharyngeal carcinomaShikha Bose, Lee-Fah Yap, Matthew Fung, et al.Cell|February 11, 2009
The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damageGrant S Stewart, Stephanie Panier, Kelly Townsend, et al.Nature|February 10, 2022
Signatures of TOP1 transcription-associated mutagenesis in cancer and germlineMartin A M Reijns, David A Parry, Thomas C Williams, et al.Blood|May 13, 2017
USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional statusAngelo Agathanggelou, Edward Smith, Nicholas J Davies, et al.Blood|January 29, 2021
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic targetEmma Kennedy, Eve Coulter, Emma Halliwell, et al.Nature|July 6, 2018
CRISPR screens identify genomic ribonucleotides as a source of PARP-trapping lesionsMichal Zimmermann, Olga Murina, Martin A M Reijns, et al.Pageof 6